ResMed Inc. (RMD) Stock Price

RMDStock

$240.33−12.73%52W

Market Cap$34.67B

P/E21.47x

PEG Ratio1.37

Div yield1.25%

Beta0.75

RMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-16.42%

Price vs S&P 500 (4W)10.14%

PEG Ratio1.37

VGM Score59.22

P/E Ratio (Annual)21.47x

Indicated Dividend Yield (Annual)1.25%

P/CF (Annual)18.11x

Book Value / Share (Quarterly)$22.70

P/TBV (Annual)8.77x

Indicated Dividend (Annual)$2.40

Revenue Growth (3Y)10.21%

Cash Flow / Share (Quarterly)$5.61

Payout Ratio (TTM)22.95%

Price vs S&P 500 (YTD)-13.05%

Gross Margin (TTM)61.06%

Net Profit Margin (TTM)26.94%

EPS (TTM)$10.44

10-Day Avg Trading Volume1.44M

EPS Excl Extra (TTM)$10.44

Revenue Growth (5Y)12.08%

EPS (Annual)$10.43

Dividend / Share (Annual)$1.60

ROI (Annual)21.03%

Gross Margin (Annual)61.06%

Net Profit Margin (5Y Avg)23.80%

Cash / Share (Quarterly)$5.06

P/E Basic Excl Extra (TTM)21.47x

Revenue Growth QoQ (YoY)8.58%

EPS Growth (5Y)26.34%

P/E Normalized (Annual)21.47x

ROA (Last FY)16.99%

Revenue Growth TTM (YoY)9.85%

EBITD / Share (TTM)$13.23

ROE (5Y Avg)22.50%

Operating Margin (TTM)33.37%

Cash Flow / Share (Annual)$5.61

P/B Ratio4.97x

P/B Ratio (Quarterly)4.29x

Net Income / Employee (Annual)$143,700

EV / Revenue (TTM)5.64x

Net Interest Coverage (TTM)661.20x

ROA (TTM)17.63%

EPS Growth QoQ (YoY)2.44%

EV / EBITDA (TTM)16.51x

EPS Incl Extra (Annual)$10.43

Current Ratio (Annual)3.10x

Quick Ratio (Quarterly)2.12x

3-Month Avg Trading Volume1.52M

52-Week Price Return-12.73%

EV / Free Cash Flow (Annual)19.59x

P/E Incl Extra (TTM)21.47x

Revenue / Employee (TTM)$533,300

Tangible BV / Share (Quarterly)$11.11

P/S Ratio (Annual)5.79x

Asset Turnover (Annual)0.63x

52-Week High$284.87

Operating Margin (5Y Avg)29.91%

EPS Excl Extra (Annual)$10.43

CapEx CAGR (5Y)8.69%

Tangible BV CAGR (5Y)5.27%

26-Week Price Return-4.49%

Quick Ratio (Annual)2.12x

13-Week Price Return18.14%

Total Debt / Equity (Annual)0.10x

Current Ratio (Quarterly)3.10x

Enterprise Value$31.90B

Revenue / Share Growth (5Y)12.14%

Asset Turnover (TTM)0.65x

Book Value / Share Growth (5Y)2.76%

Revenue / Employee (Annual)$533,300

Inventory Turnover (Annual)2.35x

Pretax Margin (Annual)33.95%

Cash / Share (Annual)$5.06

3-Month Return Std Dev38.92%

Gross Margin (5Y Avg)57.88%

Net Income / Employee (TTM)$143,700

EBITDA CAGR (5Y)15.63%

EBITDA Interim CAGR (5Y)12.99%

ROE (Last FY)23.13%

Net Interest Coverage (Annual)58.23x

EPS Basic Excl Extra (Annual)$10.43

P/FCF (TTM)20.08x

Receivables Turnover (TTM)5.58x

EV / Free Cash Flow (TTM)19.59x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$10.44

Receivables Turnover (Annual)5.58x

ROI (TTM)21.63%

Dividend Growth Rate (5Y)0.53%

P/S Ratio (TTM)5.79x

Pretax Margin (5Y Avg)29.30%

Revenue / Share (Annual)$38.71

Tangible BV / Share (Annual)$11.11

Forward P/E17.41x

Free OCF CAGR (5Y)21.31%

Price vs S&P 500 (52W)-31.29%

P/E Ratio (TTM)21.47x

EPS Growth TTM (YoY)9.76%

Year-to-Date Return-0.22%

5-Day Price Return3.39%

EPS Normalized (Annual)$10.43

ROA (5Y Avg)15.52%

Net Profit Margin (Annual)26.94%

Month-to-Date Return13.91%

Cash Flow / Share (TTM)$7.33

EBITD / Share (Annual)$13.23

EPS Growth (3Y)19.66%

Operating Margin (Annual)33.37%

LT Debt / Equity (Annual)0.06x

P/CF (TTM)18.11x

ROI (5Y Avg)19.09%

P/E Excl Extra (TTM)21.47x

LT Debt / Equity (Quarterly)0.06x

EPS Basic Excl Extra (TTM)$10.44

P/TBV (Quarterly)8.77x

Payout Ratio (Annual)22.95%

P/B Ratio (Annual)4.29x

Dividend / Share (TTM)$1.60

Inventory Turnover (TTM)2.35x

Pretax Margin (TTM)33.95%

Book Value / Share (Annual)$22.70

Price vs S&P 500 (13W)16.19%

Net Margin Growth (5Y)12.67%

Dividend Yield (TTM)1.07%

Beta0.75x

P/FCF (Annual)20.08x

Revenue / Share (TTM)$39.00

ROE (TTM)23.88%

52-Week Low$180.26

vGradeC

gGradeB

mGradeB

vgmGradeC

RMD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$2.89	$2.95	+1.98%(+$0.06)
Q1 2026	Apr 30, 2026	$2.80	$2.86	+2.15%(+$0.06)
Q4 2025	Jan 29, 2026	$2.72	$2.81	+3.15%(+$0.09)
Q3 2025	Oct 30, 2025	$2.50	$2.55	+2.05%(+$0.05)
Q2 2025	Jul 31, 2025	$2.48	$2.55	+2.77%(+$0.07)

RMD Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.69

3.64

3.60

3.48

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
RMDResMed Inc.	C	B	B	$240.33
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About ResMed Inc.

ResMed is a global leader in respiratory care devices for sleep apnea treatment, with structural growth tailwinds from rising diagnoses, aging populations, and increasing obesity prevalence. The company generates approximately two-thirds of revenue from the Americas, with the remainder from Europe, Japan, and Australia. ResMed is building competitive differentiation through digital health platforms that deliver clinical data to patients, healthcare providers, and payers in out-of-hospital settings.